Encompass Health Raises 2026 EPS Guidance to $5.96 After Q4 Beat, Shares Surge 12%
Encompass Health reported fourth-quarter adjusted EPS of $1.46, beating estimates by $0.16, while revenue rose 9.9% year-over-year to $1.54 billion. The company raised 2026 guidance to a midpoint of $5.96 per share, driving an approximately 11.9% jump in its stock.
1. Fourth-Quarter Performance
Encompass Health delivered adjusted earnings of $1.46 per share in Q4, surpassing analyst targets by $0.16. Revenue climbed 9.9% year-over-year to $1.54 billion, in line with expectations, supported by higher inpatient admissions and outpatient therapy volume.
2. Upgraded 2026 Outlook
Management boosted its full-year 2026 adjusted earnings guidance to a midpoint of $5.96 per share, exceeding prior consensus forecasts. The upgrade reflects anticipated margin expansion driven by efficiency initiatives and higher free cash flow conversion.
3. Investor Response
Shares of Encompass Health jumped roughly 11.9% on the combined strength of the earnings beat and optimistic guidance, marking one of the largest single-day moves in the past year. The stock’s low historical volatility underscores the significance of this rally for investors.